Research progress on active components and pharmacological mechanisms of Astragali Radix in immunoregulation

ZENG Wen; ZHOU Shengqiang; HUANG Jia; TAN Lingjuan; LI Zhixin; LIU Fang

doi:10.16305/j.1007-1334.2025.z20240926003

您当前的位置：

首页 >

文章列表页 >

Research progress on active components and pharmacological mechanisms of Astragali Radix in immunoregulation

更新时间：2024-12-31

- Research progress on active components and pharmacological mechanisms of Astragali Radix in immunoregulation
- Shanghai Journal of Traditional Chinese Medicine Vol. 59, Issue 1, Pages: 80-88(2025)
- 作者机构：
  
  1.湖南中医药大学（湖南长沙 410208）
  2.湖南省中医药研究院（湖南长沙 410013）
  3.湖南省中西结合医院（湖南省中医药研究院附属医院）（湖南长沙 410006）
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2025.z20240926003
  CLC：
- Published：10 January 2025，
  
  Received：26 September 2024，
- 稿件说明：
移动端阅览
曾雯,周胜强,黄佳,等.黄芪免疫调节活性成分及其药理作用进展[J].上海中医药杂志,2025,59(1):80-88.

ZENG Wen,ZHOU Shengqiang,HUANG Jia,et al.Research progress on active components and pharmacological mechanisms of Astragali Radix in immunoregulation[J].Shanghai Journal of Traditional Chinese Medicine,2025,59(1):80-88.
曾雯,周胜强,黄佳,等.黄芪免疫调节活性成分及其药理作用进展[J].上海中医药杂志,2025,59(1):80-88. DOI： 10.16305/j.1007-1334.2025.z20240926003.

ZENG Wen,ZHOU Shengqiang,HUANG Jia,et al.Research progress on active components and pharmacological mechanisms of Astragali Radix in immunoregulation[J].Shanghai Journal of Traditional Chinese Medicine,2025,59(1):80-88. DOI： 10.16305/j.1007-1334.2025.z20240926003.

摘要

免疫性疾病发生率逐年增长，目前免疫抑制剂、糖皮质激素、生物制剂等为其主要治疗手段，但存在治疗过度、治疗不足、毒副作用大等问题。黄芪及其有效成分免疫调节活性显著，具有双向调节免疫、抗炎、抗氧化应激、抗肿瘤等药理作用，在治疗肿瘤、重症肌无力、炎症性肠病、特应性皮炎、银屑病等免疫性疾病方面疗效突出。黄芪可多途径、多靶点防治免疫性疾病，现综述黄芪及其活性成分（黄芪皂苷Ⅲ、黄芪皂苷Ⅳ、环黄芪醇及黄酮类化合物）调节免疫的作用及机制，为后续临床研究提供依据。

Abstract

The incidence of immune-related diseases is rising annually. Current primary therapeutic approaches， including immunosuppressants， glucocorticoids， and biologics， present challenges such as overtreatment， undertreatment， and significant adverse toxic effects. Huangqi （Astragali Radix） and its active components show significant immunomodulatory properties and possess pharmacological effects including bidirectional immune regulation， anti-inflammatory action， antioxidative stress response， and antitumor activity， which make it effective in treating immune-related diseases such as cancer， myasthenia gravis， inflammatory bowel disease， atopic dermatitis， and psoriasis. Huangqi can prevent and treat immune diseases through multiple pathways and targets. This article reviews the mechanisms by which Huangqi and its key active compounds （Astragaloside Ⅲ， Astragaloside Ⅳ， Cycloastragenol， and various flavonoids） regulate immune responses， thereby providing a foundation for further clinical research.

关键词

黄芪免疫调节药理作用活性成分中药研究

Keywords

Huangqi （Astragali Radix）immunoregulationpharmacological effectactive componenttraditional Chinese herbal medicine research

references

GRAY J I， FARBER D L. Tissue-resident immune cells in humans［J］. Annu Rev Immunol， 2022， 40： 195-220.

GOMBART A F， PIERRE A， MAGGINI S. A review of micronutrients and the immune system-working in harmony to reduce the risk of infection［J］. Nutrients， 2020， 12（1）： 236.

SOERENS A G， KÜNZLI M， QUARNSTROM C F， et al. Functional T cells are capable of supernumerary cell division and longevity［J］. Nature， 2023， 614（7949）： 762-766.

WEEDEN C E， GAYEVSKIY V， MARCEAUX C， et al. Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancer［J］. Cancer Cell， 2023， 41（5）： 837-852.

Anon. Effect of air pollution on the human immune system［J］. Nat Med， 2022， 28（12）： 2482-2483.

BARRETT T J， CORR E M， VAN SOLINGEN C， et al. Chronic stress primes innate immune responses in mice and humans［J］. Cell Rep， 2021， 36（10）： 109595.

BASTA F， FASOLA F， TRIANTAFYLLIAS K， et al. Systemic Lupus Erythematosus （SLE） therapy： the old and the new［J］. Rheumatol Ther， 2020， 7（3）： 433-446.

佚名. 灵枢经［M］. 田代华，刘更生，整理. 北京：人民卫生出版社， 2005.

LIU J， NILE S H， XU G， et al. Systematic exploration of Astragalus membranaceus and Panax ginseng as immune regulators： Insights from the comparative biological and computational analysis［J］. Phytomedicine， 2021， 86： 153077.

SHAN H， ZHENG X， LI M. The effects of Astragalus membranaceus active extracts on autophagy-related diseases［J］. Int J Mol Sci， 2019， 20（8）： 1904.

WANG X， ZHU B， HUA Y， et al. Astragalus mongholicus Bunge and Curcuma aromatica Salisb. modulate gut microbiome and bile acid metabolism to inhibit colon cancer progression［J］. Front Microbiol， 2024， 15： 1395634.

CHOU M Y， WONG Y C， WANG S Y， et al. Potential antidepressant effects of a dietary supplement from Huáng qí and its complex in aged senescence-accelerated mouse prone-8 mice［J］. Front Nutr， 2023， 10： 1235780.

HUFFAKER M F， SANDA S， CHANDRAN S， et al. Approaches to establishing tolerance in immune mediated diseases［J］. Front Immunol， 2021， 12： 744804.

MENG Q， NIU Y， WANG R， et al. Structural characterization and immunobiological activity of polysaccharides from Astragalus oyster mushroom［J］. Molecules， 2023， 28（13）： 5280.

CHEN H Q， ZHANG N， LI C X， et al. Effects of Astragalus membranaceus on systemic lupus erythematosus in a mouse model of pregnancy［J］. Immun Inflamm Dis， 2022， 10（6）： e624.

WU X， YANG H， CHEN X， et al. Nano-herb medicine and PDT induced synergistic immunotherapy for colon cancer treatment［J］. Biomaterials， 2021， 269： 120654.

HE Y， AMER H M， XU Z， et al. Exploration of the underlying mechanism of Astragaloside Ⅲ in attenuating immunosuppression via network pharmacology and vitro/vivo pharmacological validation［J］. J Ethnopharmacol， 2024， 330： 118235.

ZHANG X， LI X， MA W， et al. Astragaloside Ⅳ restores Th17/Treg balance via inhibiting CXCR4 to improve chronic obstructive pulmonary disease［J］. Immunopharmacol Immunotoxicol， 2023， 45（6）： 682-691.

WENG S， HUANG L， CAI B， et al. Astragaloside Ⅳ ameliorates experimental autoimmune myasthenia gravis by regulating CD4 + T cells and altering gut microbiota［J］. Chin Med， 2023， 18（1）： 97.

YANG L， HAN X， YUAN J， et al. Early astragaloside Ⅳ administration attenuates experimental autoimmune encephalomyelitis in mice by suppressing the maturation and function of dendritic cells［J］. Life Sci， 2020， 249： 117448.

DENG G， ZHOU L， WANG B， et al. Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-Ⅰdegradation［J］. J Immunother Cancer， 2022， 10（10）： e004874.

ZHU L H， LIANG Y P， YANG L， et al. Cycloastragenol induces apoptosis and protective autophagy through AMPK/ULK1/mTOR axis in human non-small cell lung cancer cell lines［J］. J Integr Med， 2024， 22（4）： 503-514.

HWANG S T， KIM C， LEE J H， et al. Cycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells［J］. Phytomedicine， 2019， 59： 152907.

XIA J， ZHANG Y， WANG Q， et al. Cycloastragenol restrains keratinocyte hyperproliferation by promoting autophagy via the miR-145/STC1/Notch1 axis in psoriasis［J］. Immunopharmacol Immunotoxicol， 2024， 46（2）： 229-239.

DENG G， CHEN W， WANG P， et al. Inhibition of NLRP3 inflammasome-mediated pyroptosis in macrophage by cycloastragenol contributes to amelioration of imiquimod-induced psoriasis-like skin inflammation in mice［J］. Int Immunopharmacol， 2019， 74： 105682.

ZHOU Z W， ZHU X Y， LI S Y， et al. Formononetin inhibits mast cell degranulation to ameliorate compound 48/80-induced pseudoallergic reactions［J］. Molecules， 2023， 28（13）： 5271.

LAN H， QIU W， WU J， et al. Formononetin reverses Treg/Th17 imbalance in immune-mediated bone marrow failure mice by regulating the PI3K/Akt signaling pathway［J］. Chin Med， 2024， 19（1）： 55.

HU Y， ZHAI W， TAN D， et al. Uncovering the effects and molecular mechanism of Astragalus membranaceus （Fisch.） Bunge and its bioactive ingredients formononetin and calycosin against colon cancer： An integrated approach based on network pharmacology analysis coupled with experimental validation and molecular docking［J］. Front Pharmacol， 2023， 14： 1111912.

QU N， QU J， HUANG N， et al. Calycosin induces autophagy and apoptosis via Sestrin2/AMPK/mTOR in human papillary thyroid cancer cells［J］. Front Pharmacol， 2022， 13： 1056687.

CHEN J， MA H， MENG Y， et al. Analysis of the mechanism underlying diabetic wound healing acceleration by Calycosin-7-glycoside using network pharmacology and molecular docking［J］. Phytomedicine， 2023， 114： 154773.

WANG J， CHEN M， WANG S， et al. Identification of phytogenic compounds with antioxidant action that protect porcine intestinal epithelial cells from hydrogen peroxide induced oxidative damage［J］. Antioxidants （Basel）， 2022， 11（11）： 2134.

LI K， LI S， DU Y， et al. Screening and structure study of active components of Astragalus polysaccharide for injection based on different molecular weights［J］. J Chromatogr B Analyt Technol Biomed Life Sci， 2020， 1152： 122255.

CHEN G， JIANG N， ZHENG J， et al. Structural characterization and anti-inflammatory activity of polysaccharides from Astragalus membranaceus［J］. Int J Biol Macromol， 2023， 241： 124386.

DENG Y， SONG L， HUANG J， et al. Astragalus polysaccharides ameliorates experimental colitis by regulating memory B cells metabolism［J］. Chem Biol Interact， 2024， 394： 110969.

WANG H， ZHU W， HONG Y， et al. Astragalus polysaccharides attenuate chemotherapy-induced immune injury by modulating gut microbiota and polyunsaturated fatty acid metabolism［J］. Phytomedicine， 2024， 128： 155492.

SHEN L， LUO H， FAN L， et al. Potential immunoregulatory mechanism of plant saponins： A review［J］. Molecules， 2023， 29（1）： 113.

CHEN X， CHEN X， GAO J， et al. Astragaloside Ⅲ enhances anti-tumor response of NK cells by elevating NKG2D and IFN-γ［J］. Front Pharmacol， 2019， 10： 898.

REN Y， GAO F， LI B， et al. A precise efficacy determination strategy of traditional Chinese herbs based on Q-markers： Anticancer efficacy of Astragali radix as a case［J］. Phytomedicine， 2022， 102： 154155.

LIANG Y， CHEN B， LIANG D， et al. Pharmacological effects of Astragaloside Ⅳ： A review［J］. Molecules， 2023， 28（16）： 6118.

WCULEK S K， CUETO F J， MUJAL A M， et al. Dendritic cells in cancer immunology and immunotherapy［J］. Nat Rev Immunol， 2020， 20（1）： 7-24.

TIAN L， ZHAO J L， KANG J Q， et al. Astragaloside Ⅳ alleviates the experimental DSS-induced colitis by remodeling macrophage polarization through STAT signaling［J］. Front Immunol， 2021， 12： 740565.

TAN J， YI J， CAO X， et al. Untapping the potential of Astragaloside Ⅳ in the battle against respiratory diseases［J］. Drug Des Devel Ther， 2023， 17： 1963-1978.

SONG S， LI Y， LIU X， et al. Study on the biotransformation and activities of Astragalosides from Astragali Radix in vitro and in vivo［J］. J Agric Food Chem， 2023， 71（46）： 17924-17946.

FAN X， FAN Z， YANG Z， et al. Flavonoids-natural gifts to promote health and longevity［J］. Int J Mol Sci， 2022， 23（4）： 2176.

HAN X Y， XU N， YUAN J F， et al. Total flavonoids of Astragalus inhibit activated CD4+T cells and regulate differentiation of Th17/Th1/Treg cells in experimental autoimmune encephalomyelitis mice by JAK/STAT and NF -κB signaling pathways［J］. Am J Chin Med， 2023， 51（5）： 1233-1248.

YANG C G， MAO X L， WU J F， et al. Amelioration of lung fibrosis by total flavonoids of Astragalus via inflammatory modulation and epithelium regeneration［J］. Am J Chin Med， 2023， 51（2）： 373-389.

SUN L， WANG X， SAREDY J， et al. Innate-adaptive immunity interplay and redox regulation in immune response［J］. Redox Biol， 2020， 37： 101759.

CHEN H， LOU Y， LIN S， et al. Formononetin， a bioactive isoflavonoid constituent from Astragalus membranaceus （Fisch.） Bunge， ameliorates type 1 diabetes mellitus via activation of Keap1/Nrf2 signaling pathway： An integrated study supported by network pharmacology and experimental validation［J］. J Ethnopharmacol， 2024， 322： 117576.

ALIYA S， ALHAMMADI M， PARK U， et al. The potential role of formononetin in cancer treatment： An updated review［J］. Biomed Pharmacother， 2023， 168： 115811.

BONNIN E， RODRIGO RIESTRA M， MARZIALI F， et al. CD74 supports accumulation and function of regulatory T cells in tumors［J］. Nat Commun， 2024， 15（1）： 3749.

LI J， HUANG Z， WANG P， et al. Therapeutic targets of formononetin for treating prostate cancer at the single-cell level［J］. Aging， 2024， 16（12）： 10380-10401.

DENG M， CHEN H， LONG J， et al. Calycosin： a review of its pharmacological effects and application prospects［J］. Expert Rev Anti Infect Ther， 2021， 19（7）： 911-925.

MA X， DENG G， TIAN N， et al. Calycosin enhances Treg differentiation for alleviating skin inflammation in atopic dermatitis［J］. J Ethnopharmacol， 2024， 326： 117883.

SHARIFIAGHDAM M， SHAABANI E， FARIDI-MAJIDI R， et al. Macrophages as a therapeutic target to promote diabetic wound healing［J］. Mol Ther， 2022， 30（9）： 2891-2908.

TANG Z， HUANG G. Extraction， structure， and activity of polysaccharide from Radix astragali［J］. Biomed Pharmacother， 2022， 150： 113015.

ANDRABI S M， SHARMA N S， KARAN A，et al. Nitric Oxide： Physiological functions， delivery， and biomedical applications［J］. Adv Sci （Weinh）， 2023， 10（30）： e2303259.

GUO Y， WANG L， LIU K， et al. A rapid and accurate UHPLC method for determination of monosaccharides in polysaccharides of different sources of Radix Astragali and its immune activity analysis［J］. Molecules， 2024， 29（10）： 2287.

文雨薇，李科，吕弯弯，等. 黄芪多糖APS-Ⅰ、APS-Ⅱ制备及其对溃疡性结肠炎小鼠抗炎活性［J］. 中草药， 2024， 55（14）： 4759-4770.

XU Q， CHENG W， WEI J， et al. Synergist for antitumor therapy： Astragalus polysaccharides acting on immune microenvironment［J］. Discov Oncol， 2023， 14（1）： 179.

BAMODU O A， KUO K T， WANG C H， et al. Astragalus polysaccharides （PG2） enhances the M1 polarization of macrophages， functional maturation of dendritic cells， and T cell-mediated anticancer immune responses in patients with lung cancer［J］. Nutrients， 2019， 11（10）： 2264.

何香川，刘明斌，张晓燕，等. 靶向肿瘤微环境（TME）免疫治疗策略的研究进展［J］. 复旦学报（医学版）， 2020， 47（1）： 128-134.

LI S， SUN Y， HUANG J， et al. Anti-tumor effects and mechanisms of Astragalus membranaceus （AM） and its specific immunopotentiation： Status and prospect［J］. J Ethnopharmacol， 2020， 258： 112797.

LI Z， QI J， GUO T， et al. Research progress of Astragalus membranaceus in treating peritoneal metastatic cancer［J］. J Ethnopharmacol， 2023， 305： 116086.

SHEIK A， KIM K， VARAPRASAD G L， et al. The anti-cancerous activity of adaptogenic herb Astragalus membranaceus［J］. Phytomedicine， 2021， 91： 153698.

SHENG F， YANG S， LI M， et al. Research progress on the anti-cancer effects of Astragalus membranaceus saponins and their mechanisms of action［J］. Molecules， 2024， 29（14）： 3388.

PENG Q， YU Y， YE L， et al. Astragalus polysaccharides sensitize ovarian cancer stem cells to PARPi by inhibiting mitophagy via PINK1/Parkin signaling［J］. iScience， 2024， 27（8）： 110376.

齐彦爽，李肖，秦雪梅，等. 黄芪总黄酮联合顺铂对Lewis荷瘤小鼠抗癌作用的研究［J］. 药学学报， 2020， 55（5）： 930-940.

BRIL V， DRUŻDŻ A， GROSSKREUTZ J， et al. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis （MycarinG）： a randomised， double-blind， placebo-controlled， adaptive phase 3 study［J］. Lancet Neurol， 2023， 22（5）： 383-394.

盛昭园，陈建，应汝炯，等.基于海派中医特色的重症肌无力一体化综合诊疗专家共识［J］.上海中医药杂志，2024， 58（S1）： 41-47.

ZHANG J， HUANG J， LAN J， et al. Astragaloside Ⅳ protects against autoimmune myasthenia gravis in rats via regulation of mitophagy and apoptosis［J］. Mol Med Rep， 2024， 30（1）： 129.

LEE M， CHANG E B. Inflammatory Bowel Diseases （IBD） and the microbiome-searching the crime scene for clues［J］. Gastroenterology， 2021， 160（2）： 524-537.

WU Z Y， SANG L X， CHANG B. Isoflavones and inflammatory bowel disease［J］. World J Clin Cases， 2020， 8（11）： 2081-2091.

HOU M， LENG Y， SHI Y， et al. Astragalus membranaceus as a drug candidate for inflammatory bowel disease： the preclinical evidence［J］. Am J Chin Med， 2023， 51（6）： 1501-1526.

ZHANG X， ZHANG F， LI Y， et al. Blockade of PI3K/AKT signaling pathway by Astragaloside Ⅳ attenuates ulcerative colitis via improving the intestinal epithelial barrier［J］. J Transl Med， 2024， 22（1）： 406.

ZHONG Y， LIU W， XIONG Y， et al. Astragaloside Ⅳ alleviates ulcerative colitis by regulating the balance of Th17/Treg cells［J］. Phytomedicine， 2022， 104： 154287.

ZHONG Y， XIAO Q， KANG Z， et al. Astragalus polysaccharide alleviates ulcerative colitis by regulating the balance of Tfh/Treg cells［J］. Int Immunopharmacol， 2022， 111： 109108.

WAN Q， HUANG J， XIAO Q， et al. Astragalus polysaccharide alleviates ulcerative colitis by regulating the balance of mTh17/mTreg cells through TIGIT/CD155 signaling［J］. Molecules， 2024， 29（1）： 241.

HUO Z， LI J， LI X， et al. Functional fractions of Astragalus polysaccharides as a potential prebiotic to alleviate ulcerative colitis［J］. Int J Biol Macromol， 2024， 271（Pt 1）： 132580.

TOKUYAMA M， MABUCHI T. New treatment addressing the pathogenesis of psoriasis［J］. Int J Mol Sci， 2020， 21（20）： 7488.

刘欣，朱圣杰，严格，等.从体液代谢论汗法治疗银屑病的现代机制研究［J］.上海中医药杂志，2022， 56（6）： 17-22.

EBRAHIMI A， MEHRABI M， MIRAGHAEE S S， et al. Flavonoid compounds and their synergistic effects： Promising approaches for the prevention and treatment of psoriasis with emphasis on keratinocytes - A systematic and mechanistic review［J］. Int Immunopharmacol， 2024， 138： 112561.

XU H T， ZHENG Q， TAI Z G， et al. Formononetin attenuates psoriasiform inflammation by regulating interferon signaling pathway［J］. Phytomedicine， 2024， 128： 155412.

中华医学会皮肤性病学分会，中国医师协会皮肤科医师分会. 中国中重度特应性皮炎诊疗临床路径专家共识（2023版）［J］. 中华皮肤科杂志， 2023， 56（11）： 1000-1007.

YUAN W， CHEN Y， ZHOU Y， et al. Formononetin attenuates atopic dermatitis by upregulating A20 expression via activation of G protein-coupled estrogen receptor［J］. J Ethnopharmacol， 2021， 266： 113397.

ZHANG J， XIAO Y， HU J， et al. Lipid metabolism in type 1 diabetes mellitus： Pathogenetic and therapeutic implications［J］. Front Immunol， 2022， 13： 999108.

ZHOU X， WANG L L， TANG W J， et al. Astragaloside Ⅳ inhibits protein tyrosine phosphatase 1B and improves insulin resistance in insulin-resistant HepG2 cells and triglyceride accumulation in oleic acid （OA）-treated HepG2 cells［J］. J Ethnopharmacol， 2021， 268： 113556.

LIU S， WANG L， ZHANG Z， et al. The potential of astragalus polysaccharide for treating diabetes and its action mechanism［J］. Front Pharmacol， 2024， 15： 1339406.

HAAHTELA T， ALENIUS H， LEHTIMÄKI J， et al. Immunological resilience and biodiversity for prevention of allergic diseases and asthma［J］. Allergy， 2021， 76（12）： 3613-3626.

D'AVINO D， CERQUA I， ULLAH H， et al. Beneficial effects of Astragalus membranaceus （Fisch.） Bunge extract in controlling inflammatory response and preventing asthma features［J］. Int J Mol Sci， 2023， 24（13）： 10954.

ZHOU Z W， JI K， ZHU X Y， et al. Natural isoflavone formononetin inhibits IgE-mediated mast cell activation and allergic inflammation by increasing IgE receptor degradation［J］. Food Funct， 2023， 14（6）： 2857-2869.

ZHU X， CAO Y， SU M， et al. Cycloastragenol alleviates airway inflammation in asthmatic mice by inhibiting autophagy［J］. Mol Med Rep， 2021， 24（5）： 805.

TIAN C， LIU Q， ZHANG X， et al. Blocking group 2 innate lymphoid cell activation and macrophage M2 polarization： potential therapeutic mechanisms in ovalbumin-induced allergic asthma by calycosin［J］. BMC Pharmacol Toxicol， 2024， 25（1）： 30.

YU S， PENG W， QIU F， et al. Research progress of astragaloside Ⅳ in the treatment of atopic diseases［J］. Biomed Pharmacother， 2022， 156： 113989.

YUAN F， YANG Y， LIU L， et al. Research progress on the mechanism of astragaloside Ⅳ in the treatment of asthma［J］. Heliyon， 2023， 9（11）： e22149.

JANG S ， KWON E J ， LEE J J. Rheumatoid arthritis： Pathogenic roles of diverse immune cells［J］. Int J Mol Sci， 2022， 23（2）： 905.

JIANG H， FAN C， LU Y， et al. Astragaloside regulates lncRNA LOC100912373 and the miR-17-5p/PDK1 axis to inhibit the proliferation of fibroblast-like synoviocytes in rats with rheumatoid arthritis［J］. Int J Mol Med， 2021， 48（1）： 130.

马慧莱，侯宇芯，王爱成，等. 基于网络药理学比较黄芪桂枝五物汤和四神煎治疗类风湿关节炎的作用机制［J］. 中医杂志， 2022， 63（20）： 1965-1974.

林婉娜，苏慧琳，李慧敏，等. 黄芪桂枝五物汤抗类风湿性关节炎的作用机制［J］. 中国实验方剂学杂志， 2022， 28（9）： 9-15.

卢雯雯，裘一婧，范小芬，等. 基于UPLC-LTQ-Orbitrap-MS和网络药理学探索黄芪桂枝五物汤治疗类风湿关节炎的作用机制及实验验证［J］. 中国中药杂志， 2021， 46（24）： 6454-6464.

XU Y， LI S， WANG Y， et al. Fangji Huangqi Decoction alleviates rheumatoid arthritis through regulating HIF-1α mediated the angiogenesis and the balance between autophagy and apoptosis［J］. J Ethnopharmacol， 2024， 329： 118061.

CHI X， HUANG M， TU H， et al. Innate and adaptive immune abnormalities underlying autoimmune diseases： the genetic connections［J］. Sci China Life Sci， 2023， 66（7）： 1482-1517.

邹传宗，吴秋钰. HPLC法测定不同产地黄芪中黄芪甲苷的含量［J］. 安徽农业科学， 2022， 50（1）： 208-209， 227.

YANG M， LI Z， LIU L， et al. Ecological niche modeling of Astragalus membranaceus var. mongholicus medicinal plants in Inner Mongolia， China［J］. Sci Rep， 2020， 10（1）： 12482.

WU H， CUI H， TIAN Y， et al. Exogenous ethephon treatment on the biosynthesis and accumulation of astragaloside Ⅳ in Astragalus membranaceus Bge. Var. Mongholicus （Bge.） Hsiao［J］. Bot Stud， 2024， 65（1）： 16.

SHANG Q， LIU W， LESLIE F， et al. Nano-formulated delivery of active ingredients from traditional Chinese herbal medicines for cancer immunotherapy［J］. Acta Pharm Sin B， 2024， 14（4）： 1525-1541.

LIU Q， LI J， GU M， et al. High-throughput phytochemical unscrambling of flowers originating from Astragalus membranaceus （Fisch.） Bge. var. mongholicus （Bge.） P. K. Hsiao and Astragalus membranaceus （Fisch.） Bug. by applying the intagretive plant metabolomics method using UHPLC-Q-TOF-MS/MS［J］. Molecules， 2023， 28（16）： 6115.

Views

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism of Elian Granules modulating JAK2/STAT3 pathway for treatment of chronic atrophic gastritis

Study on mechanism of Chenpi in treatment of anemia of chronic disease with Yigong Powder based on network pharmacology and experimental validation

Role of NLRP3 inflammasome in osteo‑sarcopenia and advances in intervention with traditional Chinese medicine monomers

Intervention effect and mechanism of Jianpi Bushen Formula on amyotrophic lateral sclerosis mouse

Protective effects of Shenqi Granules and its component formulas on injured podocytes

Related Author

JIA Qingling

YI Zhirong

JIANG Kailin

GU Zhijian

CAI Gan

LING Jianghong

HU Jie

ZHENG Qin

Related Institution

Department of Chinese Medicine， The First Affiliated Hospital of Guangxi Medical University

Department of Gastroenterology， Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Traditional Chinese Medicine， Shanghai Jiading Huating Town Community Health Service Center

Department of Hematology， Baoshan Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Spinal Orthopedics Ⅱ， Gansu Provincial Hospital of Traditional Chinese Medicine

⁰